FDA Grants Emergency Use Authorization for Roche’s Cobas Riat SARS-CoV-2, Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Tests

Cobas is classified as a 4-in-1 molecular test that can identify SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus from a single nasopharyngeal or anterior nasal swab sample.